129 related articles for article (PubMed ID: 19049345)
1. A novel PDE2A reporter cell line: characterization of the cellular activity of PDE inhibitors.
Wunder F; Gnoth MJ; Geerts A; Barufe D
Mol Pharm; 2009; 6(1):326-36. PubMed ID: 19049345
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line.
Wunder F; Tersteegen A; Rebmann A; Erb C; Fahrig T; Hendrix M
Mol Pharmacol; 2005 Dec; 68(6):1775-81. PubMed ID: 16150925
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3.
Surapisitchat J; Jeon KI; Yan C; Beavo JA
Circ Res; 2007 Oct; 101(8):811-8. PubMed ID: 17704206
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T
Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of receptor guanylyl cyclase reporter cell lines.
Wunder F; Woermann A; Geerts A; Milde M
Eur J Pharmacol; 2013 Jan; 698(1-3):131-6. PubMed ID: 23178524
[TBL] [Abstract][Full Text] [Related]
6. A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway.
Wunder F; Stasch JP; Hütter J; Alonso-Alija C; Hüser J; Lohrmann E
Anal Biochem; 2005 Apr; 339(1):104-12. PubMed ID: 15766716
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages.
Rentsendorj O; D'Alessio FR; Pearse DB
J Leukoc Biol; 2014 Nov; 96(5):907-15. PubMed ID: 25063878
[TBL] [Abstract][Full Text] [Related]
8. Characterization of inhibitors of phosphodiesterase 1C on a human cellular system.
Dunkern TR; Hatzelmann A
FEBS J; 2007 Sep; 274(18):4812-24. PubMed ID: 17697115
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel, sensitive cell-based corin assay.
Lambertz P; Theisen L; Längst N; Garvie CW; MacDonald BT; Yu J; Elowe NH; Zubov D; Kaushik VK; Wunder F
Biochem Pharmacol; 2019 Feb; 160():62-70. PubMed ID: 30553787
[TBL] [Abstract][Full Text] [Related]
10. Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present).
Trabanco AA; Buijnsters P; Rombouts FJ
Expert Opin Ther Pat; 2016 Aug; 26(8):933-46. PubMed ID: 27321640
[TBL] [Abstract][Full Text] [Related]
11. Identification of lead BAY60-7550 analogues as potential inhibitors that utilize the hydrophobic groove in PDE2A: a molecular dynamics simulation study.
Kumar J; Umar T; Kausar T; Mobashir M; Nayeem SM; Hoda N
J Mol Model; 2017 Jan; 23(1):7. PubMed ID: 27966018
[TBL] [Abstract][Full Text] [Related]
12. Optimization and validation of a reporter gene assay for screening of phosphodiesterase inhibitors in a high throughput system.
Nanda K; Chatterjee M; Arya R; Mukherjee S; Saini KS; Dastidar S; Ray A
Biotechnol J; 2008 Oct; 3(9-10):1276-9. PubMed ID: 18655041
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 2A localized in the spinal cord contributes to inflammatory pain processing.
Kallenborn-Gerhardt W; Lu R; Bothe A; Thomas D; Schlaudraff J; Lorenz JE; Lippold N; Real CI; Ferreirós N; Geisslinger G; Del Turco D; Schmidtko A
Anesthesiology; 2014 Aug; 121(2):372-82. PubMed ID: 24758774
[TBL] [Abstract][Full Text] [Related]
14. Real-time monitoring of phosphodiesterase inhibition in intact cells.
Herget S; Lohse MJ; Nikolaev VO
Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of cell lines for high-throughput screening of human neuromedin U receptor subtype 2 specific agonists using a luciferase reporter gene assay.
Li X; Shen F; Zhang Y; Zhu J; Huang L; Shi Q
Eur J Pharm Biopharm; 2007 Aug; 67(1):284-92. PubMed ID: 17337170
[TBL] [Abstract][Full Text] [Related]
16. A reporter gene assay for screening of PDE4 subtype selective inhibitors.
Bora RS; Malik R; Arya R; Gupta D; Singh V; Aggarwal N; Dastidar S; Ray A; Saini KS
Biochem Biophys Res Commun; 2007 Apr; 356(1):153-8. PubMed ID: 17336928
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Phosphodiesterase-2A Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay.
Zhang C; Feng LJ; Huang Y; Wu D; Li Z; Zhou Q; Wu Y; Luo HB
J Chem Inf Model; 2017 Feb; 57(2):355-364. PubMed ID: 28055196
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the cellular activity of PDE 4 inhibitors using two novel PDE 4 reporter cell lines.
Wunder F; Quednau R; Geerts A; Barg M; Tersteegen A
Mol Pharm; 2013 Oct; 10(10):3697-705. PubMed ID: 23987244
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of Lu AF33241: A novel, brain-penetrant, dual inhibitor of phosphodiesterase (PDE) 2A and PDE10A.
Redrobe JP; Rasmussen LK; Christoffersen CT; Bundgaard C; Jørgensen M
Eur J Pharmacol; 2015 Aug; 761():79-85. PubMed ID: 25941078
[TBL] [Abstract][Full Text] [Related]
20. Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors.
Malik R; Bora RS; Gupta D; Sharma P; Arya R; Chaudhary S; Saini KS
Appl Microbiol Biotechnol; 2008 Jan; 77(5):1167-73. PubMed ID: 17952431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
